| Current Price | $1.01 | Mkt Cap | $44.6M |
|---|---|---|---|
| Open | $1.00 | P/E Ratio | 0.00 |
| Prev. Close | $1.01 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.95 - $1.02 | Volume | 341,889 |
| 52-Wk Range | $0.95 - $9.92 | Avg. Daily Vol. | 756,825 |
| Current Price | $1.01 | Mkt Cap | $44.6M |
|---|---|---|---|
| Open | $1.00 | P/E Ratio | 0.00 |
| Prev. Close | $1.01 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.95 - $1.02 | Volume | 341,889 |
| 52-Wk Range | $0.95 - $9.92 | Avg. Daily Vol. | 756,825 |
The best Bull and Bear pitches based on recency and number of recommendations.
I believe the Mydicar therapy is revolutionary and will help to boost Celladon's stock price much higher in relation to the market over the next 2-4 years. The Cupid2 study results being released later this month- if positive, will propel the stock… More
Read the most recent pitches from players about EIGR.
Recs
oscillation
(73.24)
Submitted: 5/28/2015 9:24:56 AM :
Start Price:
$32.40
NASDAQ:EIGR Score:
-183.06
nev
Recs
treasureoaks
(< 20)
Submitted: 4/22/2015 3:54:19 PM :
Start Price:
$203.85
NASDAQ:EIGR Score:
-187.20
Oversold.
Recs
Jimbyrnes1969
(< 20)
Submitted: 4/9/2015 1:25:22 PM :
Start Price:
$252.36
NASDAQ:EIGR Score:
-189.43
I believe the Mydicar therapy is revolutionary and will help to boost Celladon's stock price much higher in relation to the market over the next 2-4 years. The Cupid2 study results being released later this month- if positive, will propel the stock 300% in the short term but the real value will be when the therapy hits the market.
Find the members with the highest scoring picks in EIGR.
GreenAB (29.20) Score: +188.05
The Score Leader is the player with the highest score across all their picks in EIGR.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| GreenAB | 29.20 | 3/20/2015 |
|
NS | $405.00 | -99.75% | +88.30% | +188.05 | 0 Comment | |
| IdahoInvestor | 27.60 | 8/17/2015 |
|
5Y | $15.75 | -93.56% | +89.42% | +182.98 | 0 Comment | |
| BravoBevo | 99.97 | 2/9/2023 |
|
5Y | $2.76 | -63.23% | -3.21% | -60.02 | 0 Comment | |
|
OneBee | < 20 | 5/4/2021 |
|
3M | $8.67 | -88.29% | -4.99% | -83.30 | 0 Comment |
| foggs1 | 65.97 | 3/17/2021 |
|
5Y | $10.12 | -89.97% | +0.21% | -90.18 | 0 Comment | |
| odocoileus | 40.26 | 9/10/2020 |
|
5Y | $10.48 | -90.31% | +18.03% | -108.35 | 0 Comment | |
| drugtrader | 55.94 | 7/8/2020 |
|
5Y | $9.43 | -89.24% | +26.36% | -115.60 | 0 Comment | |
| naughtyguy | 79.31 | 8/21/2019 |
|
5Y | $10.56 | -90.39% | +35.32% | -125.71 | 0 Comment | |
| BigDreamer | 51.99 | 1/29/2018 |
|
3Y | $8.95 | -88.66% | +38.26% | -126.92 | 0 Comment | |
| jeepdrew222 | 50.67 | 8/28/2018 |
|
5Y | $12.90 | -92.13% | +36.18% | -128.32 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
